Table of Contents

1 Study Coverage

• 1.1 Albendazole Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Albendazole Market Size Growth Rate by Product
  • 1.4.2 Capsule
  • 1.4.3 Tablet
• 1.5 Market by End User
  • 1.5.1 Global Albendazole Market Size Growth Rate by End User
  • 1.5.2 Pinworm Infection Treatment
  • 1.5.3 Ascaris Infection Treatment
  • 1.5.4 Other Parasitic Infections Treatment
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Albendazole Market Size
  • 2.1.1 Global Albendazole Revenue 2014-2025
  • 2.1.2 Global Albendazole Sales 2014-2025
• 2.2 Albendazole Growth Rate by Regions
  • 2.2.1 Global Albendazole Sales by Regions
  • 2.2.2 Global Albendazole Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Albendazole Sales by Manufacturers
  • 3.1.1 Albendazole Sales by Manufacturers
  • 3.1.2 Albendazole Sales Market Share by Manufacturers
  • 3.1.3 Global Albendazole Market Concentration Ratio (CR5 and HHI)
• 3.2 Albendazole Revenue by Manufacturers
  • 3.2.1 Albendazole Revenue by Manufacturers (2014-2019)
  • 3.2.2 Albendazole Revenue Share by Manufacturers (2014-2019)
• 3.3 Albendazole Price by Manufacturers
• 3.4 Albendazole Manufacturing Base Distribution, Product Types
  • 3.4.1 Albendazole Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Albendazole Product Type
  • 3.4.3 Date of International Manufacturers Enter into Albendazole Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Albendazole Sales by Product
• 4.2 Global Albendazole Revenue by Product
• 4.3 Albendazole Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Albendazole Breakdown Data by End User

6 North America

• 6.1 North America Albendazole by Countries
  • 6.1.1 North America Albendazole Sales by Countries
  • 6.1.2 North America Albendazole Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Albendazole by Product
• 6.3 North America Albendazole by End User

7 Europe

• 7.1 Europe Albendazole by Countries
  • 7.1.1 Europe Albendazole Sales by Countries
  • 7.1.2 Europe Albendazole Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Albendazole by Product
• 7.3 Europe Albendazole by End User

8 Asia Pacific

• 8.1 Asia Pacific Albendazole by Countries
  • 8.1.1 Asia Pacific Albendazole Sales by Countries
  • 8.1.2 Asia Pacific Albendazole Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Albendazole by Product
• 8.3 Asia Pacific Albendazole by End User

9 Central & South America

• 9.1 Central & South America Albendazole by Countries
  • 9.1.1 Central & South America Albendazole Sales by Countries
  • 9.1.2 Central & South America Albendazole Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Albendazole by Product
• 9.3 Central & South America Albendazole by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Albendazole by Countries
  • 10.1.1 Middle East and Africa Albendazole Sales by Countries
  • 10.1.2 Middle East and Africa Albendazole Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Albendazole by Product
• 10.3 Middle East and Africa Albendazole by End User

11 Company Profiles

• 11.1 CHANGZHOU YABANG
  • 11.1.1 CHANGZHOU YABANG Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 CHANGZHOU YABANG Albendazole Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 CHANGZHOU YABANG Albendazole Products Offered
  • 11.1.5 CHANGZHOU YABANG Recent Development
• 11.2 GlaxoSmithKline
  • 11.2.1 GlaxoSmithKline Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 GlaxoSmithKline Albendazole Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 GlaxoSmithKline Albendazole Products Offered
  • 11.2.5 GlaxoSmithKline Recent Development
• 11.3 Huazhong Pharmaceutical
  • 11.3.1 Huazhong Pharmaceutical Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Huazhong Pharmaceutical Albendazole Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Huazhong Pharmaceutical Albendazole Products Offered
  • 11.3.5 Huazhong Pharmaceutical Recent Development
• 11.4 Hubei Zhongjia-chem Pharmaceutical
  • 11.4.1 Hubei Zhongjia-chem Pharmaceutical Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Hubei Zhongjia-chem Pharmaceutical Albendazole Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Hubei Zhongjia-chem Pharmaceutical Albendazole Products Offered
  • 11.4.5 Hubei Zhongjia-chem Pharmaceutical Recent Development
• 11.5 HUBEI KEYI
  • 11.5.1 HUBEI KEYI Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 HUBEI KEYI Albendazole Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 HUBEI KEYI Albendazole Products Offered
  • 11.5.5 HUBEI KEYI Recent Development
• 11.6 Sequent Scientifi
  • 11.6.1 Sequent Scientifi Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Sequent Scientifi Albendazole Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Sequent Scientifi Albendazole Products Offered
  • 11.6.5 Sequent Scientifi Recent Development
• 11.7 Lasa Laboratory Pvt Ltd
  • 11.7.1 Lasa Laboratory Pvt Ltd Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Lasa Laboratory Pvt Ltd Albendazole Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Lasa Laboratory Pvt Ltd Albendazole Products Offered
  • 11.7.5 Lasa Laboratory Pvt Ltd Recent Development
• 11.8 K.A.Malle Pharmaceuticals
  • 11.8.1 K.A.Malle Pharmaceuticals Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 K.A.Malle Pharmaceuticals Albendazole Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 K.A.Malle Pharmaceuticals Albendazole Products Offered
  • 11.8.5 K.A.Malle Pharmaceuticals Recent Development
• 11.9 Supharma Chem
  • 11.9.1 Supharma Chem Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Supharma Chem Albendazole Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Supharma Chem Albendazole Products Offered
  • 11.9.5 Supharma Chem Recent Development
• 11.10 Salius Pharma
  • 11.10.1 Salius Pharma Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Salius Pharma Albendazole Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Salius Pharma Albendazole Products Offered
  • 11.10.5 Salius Pharma Recent Development
• 11.11 Fredun Pharmaceuticals Ltd
• 11.12 Ashish life Science Pvt. Ltd.
• 11.13 AdvacarePharma
• 11.14 MANAV DRUGS
• 11.15 Leo Bio-Care Pvt.

12 Future Forecast

• 12.1 Albendazole Market Forecast by Regions
  • 12.1.1 Global Albendazole Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Albendazole Revenue Forecast by Regions 2019-2025
• 12.2 Albendazole Market Forecast by Product
  • 12.2.1 Global Albendazole Sales Forecast by Product 2019-2025
  • 12.2.2 Global Albendazole Revenue Forecast by Product 2019-2025
• 12.3 Albendazole Market Forecast by End User
• 12.4 North America Albendazole Forecast
• 12.5 Europe Albendazole Forecast
• 12.6 Asia Pacific Albendazole Forecast
• 12.7 Central & South America Albendazole Forecast
• 12.8 Middle East and Africa Albendazole Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Albendazole Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Albendazole market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Albendazole market based on company, product type, end user and key regions.

This report studies the global market size of Albendazole in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Albendazole in these regions.
This research report categorizes the global Albendazole market by top players/brands, region, type and end user. This report also studies the global Albendazole market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
CHANGZHOU YABANG
GlaxoSmithKline
Huazhong Pharmaceutical
Hubei Zhongjia-chem Pharmaceutical
HUBEI KEYI
Sequent Scientifi
Lasa Laboratory Pvt Ltd
K.A.Malle Pharmaceuticals
Supharma Chem
Salius Pharma
Fredun Pharmaceuticals Ltd
Ashish life Science Pvt. Ltd.
AdvacarePharma
MANAV DRUGS
Leo Bio-Care Pvt.

Market size by Product
Capsule
Tablet
Market size by End User
Pinworm Infection Treatment
Ascaris Infection Treatment
Other Parasitic Infections Treatment

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Albendazole market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Albendazole market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Albendazole companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Albendazole submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Albendazole are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Albendazole market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.